+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Lentiviral Vector Market Size, Share & Trends Analysis Report by Product, Indication, End Use, Region, and Growth Forecasts, 2026-2033

  • PDF Icon

    Report

  • 120 Pages
  • April 2026
  • Region: Global
  • Grand View Research
  • ID: 6241288
The global lentiviral vector market size was valued at USD 601.1 million in 2025 and is projected to reach USD 1.14 billion by 2033, growing at a CAGR of 8.4% from 2026 to 2033. Growth is driven by rising demand for gene and cell therapies, increasing clinical research, and advancements in vector manufacturing. However, high costs and regulatory complexities may hinder market expansion.

Global Lentiviral Vector Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, the analyst has segmented the global lentiviral vector market report on the basis of product, indication, end use, and region.

Product Outlook (Revenue, USD Million, 2021-2033)

  • 1st-Generation
  • 2nd-Generation
  • 3rd-Generation

Indication Outlook (Revenue, USD Million, 2021-2033)

  • HIV
  • Β-Thalassemia
  • X-Linked Adrenoleukodystrophy
  • Metachromatic Leukodystrophy
  • Wiskott-Aldrich Syndrome

End Use Outlook (Revenue, USD Million, 2021-2033)

  • Pharmaceutical and Biotechnology Companies
  • Academic & Research Institutes
  • CROs & CMOs

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • MEA
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Product Segment
1.2.2. Indication Segment
1.2.3. End Use Segment
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Lentiviral Vector Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.2.3. Market opportunity analysis
3.2.4. Market challenge analysis
3.3. Case Study Insights
3.4. Lentiviral Vector Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.2. PESTEL Analysis
Chapter 4. Lentiviral Vector Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Lentiviral Vector Market Product Movement Analysis
4.3. Global Lentiviral Vector Market Size & Trend Analysis, by Product Type, 2021 to 2033 (USD Million)
4.4. 1st-Generation
4.4.1. 1st-generation market estimates and forecasts 2021 to 2033 (USD Million)
4.5. 2nd-Generation
4.5.1. 2nd-generation market estimates and forecasts 2021 to 2033 (USD Million)
4.6. 3rd-Generation
4.6.1. 3rd-generation market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Lentiviral Vector Market: Indication Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Lentiviral Vector Market Indication Movement Analysis
5.3. Global Lentiviral Vector Market Size & Trend Analysis, by Indication, 2021 to 2033 (USD Million)
5.4. HIV
5.4.1. HIV market estimates and forecasts 2021 to 2033 (USD Million)
5.5. ?-Thalassemia
5.5.1. ?-thalassemia market estimates and forecasts 2021 to 2033 (USD Million)
5.6. X-Linked Adrenoleukodystrophy
5.6.1. X-Linked adrenoleukodystrophy market estimates and forecasts 2021 to 2033 (USD Million)
5.7. Metachromatic Leukodystrophy
5.7.1. Metachromatic leukodystrophy market estimates and forecasts 2021 to 2033 (USD Million)
5.8. Wiskott-Aldrich Syndrome
5.8.1. Wiskott-aldrich syndrome market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Lentiviral Vector Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Lentiviral Vector Market End Use Movement Analysis
6.3. Global Lentiviral Vector Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
6.4. Pharmaceutical and Biotechnology Companies
6.4.1. Pharmaceutical and biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)
6.5. Academic & Research Institutes
6.5.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
6.6. CROs & CMOs
6.6.1. CROs & CMOs market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Lentiviral Vector Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2025 & 2033
7.2. Regional Market Dashboard
7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
7.4. North America
7.4.1. Market estimates and forecasts 2021 to 2033 (USD Million)
7.4.2. U.S.
7.4.3. Canada
7.4.4. Mexico
7.5. Europe
7.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
7.5.2. UK
7.5.3. Germany
7.5.4. France
7.5.5. Italy
7.5.6. Spain
7.5.7. Norway
7.5.8. Sweden
7.5.9. Denmark
7.6. Asia-Pacific
7.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
7.6.2. Japan
7.6.3. China
7.6.4. India
7.6.5. Australia
7.6.6. South Korea
7.6.7. Thailand
7.7. Latin America
7.7.1. Market estimates and forecasts 2021 to 2033 (USD Million)
7.7.2. Brazil
7.7.3. Argentina
7.8. MEA
7.8.1. Market estimates and forecasts 2021 to 2033 (USD Million)
7.8.2. South Africa
7.8.3. Saudi Arabia
7.8.4. UAE
7.8.5. Kuwait
Chapter 8. Competitive Landscape
8.1. Company/Competition Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2025
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific, Inc.
8.4.2. Merck KGaA
8.4.3. OriGene Technologies Inc.
8.4.4. FinVector Oy
8.4.5. Sino Biological Inc.
8.4.6. Oxford Biomedica
8.4.7. Lonza
8.4.8. Vector Biolabs
8.4.9. Takara Bio Inc.
8.4.10. Sirion-Biotech GmbH (Revvity)
List of Tables
Table 1 List of abbreviation
Table 2 Global lentiviral vector market, by region, 2021-2033 (USD Million)
Table 3 Global lentiviral vector market, by product, 2021-2033 (USD Million)
Table 4 Global lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 5 Global lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 6 North America lentiviral vector market, by country, 2021-2033 (USD Million)
Table 7 North America lentiviral vector market, by product, 2021-2033 (USD Million)
Table 8 North America lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 9 North America lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 10 U.S. lentiviral vector market, by product, 2021-2033 (USD Million)
Table 11 U.S. lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 12 U.S. lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 13 Canada lentiviral vector market, by product, 2021-2033 (USD Million)
Table 14 Canada lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 15 Canada lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 16 Mexico lentiviral vector market, by product, 2021-2033 (USD Million)
Table 17 Mexico lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 18 Mexico lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 19 Europe lentiviral vector market, by country, 2021-2033 (USD Million)
Table 20 Europe lentiviral vector market, by product, 2021-2033 (USD Million)
Table 21 Europe lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 22 Europe lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 23 Germany lentiviral vector market, by product, 2021-2033 (USD Million)
Table 24 Germany lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 25 Germany lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 26 UK lentiviral vector market, by product, 2021-2033 (USD Million)
Table 27 UK lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 28 UK lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 29 France lentiviral vector market, by product, 2021-2033 (USD Million)
Table 30 France lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 31 France lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 32 Italy lentiviral vector market, by product, 2021-2033 (USD Million)
Table 33 Italy lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 34 Italy lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 35 Spain lentiviral vector market, by product, 2021-2033 (USD Million)
Table 36 Spain lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 37 Spain lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 38 Denmark lentiviral vector market, by product, 2021-2033 (USD Million)
Table 39 Denmark lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 40 Denmark lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 41 Sweden lentiviral vector market, by product, 2021-2033 (USD Million)
Table 42 Sweden lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 43 Sweden lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 44 Norway lentiviral vector market, by product, 2021-2033 (USD Million)
Table 45 Norway lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 46 Norway lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 47 Asia-Pacific lentiviral vector market, by country, 2021-2033 (USD Million)
Table 48 Asia-Pacific lentiviral vector market, by product, 2021-2033 (USD Million)
Table 49 Asia-Pacific lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 50 Asia-Pacific lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 51 China lentiviral vector market, by product, 2021-2033 (USD Million)
Table 52 China lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 53 China lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 54 Japan lentiviral vector market, by product, 2021-2033 (USD Million)
Table 55 Japan lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 56 Japan lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 57 India lentiviral vector market, by product, 2021-2033 (USD Million)
Table 58 India lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 59 India lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 60 South Korea lentiviral vector market, by product, 2021-2033 (USD Million)
Table 61 South Korea lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 62 South Korea lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 63 Australia lentiviral vector market, by product, 2021-2033 (USD Million)
Table 64 Australia lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 65 Australia lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 66 Thailand lentiviral vector market, by product, 2021-2033 (USD Million)
Table 67 Thailand lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 68 Thailand lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 69 Latin America lentiviral vector market, by country, 2021-2033 (USD Million)
Table 70 Latin America lentiviral vector market, by product, 2021-2033 (USD Million)
Table 71 Latin America lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 72 Latin America lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 73 Brazil lentiviral vector market, by product, 2021-2033 (USD Million)
Table 74 Brazil lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 75 Brazil lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 76 Argentina lentiviral vector market, by product, 2021-2033 (USD Million)
Table 77 Argentina lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 78 Argentina lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 79 MEA lentiviral vector market, by country, 2021-2033 (USD Million)
Table 80 MEA lentiviral vector market, by product, 2021-2033 (USD Million)
Table 81 MEA lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 82 MEA lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 83 South Africa lentiviral vector market, by product, 2021-2033 (USD Million)
Table 84 South Africa lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 85 South Africa lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 86 Saudi Arabia lentiviral vector market, by product, 2021-2033 (USD Million)
Table 87 Saudi Arabia lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 88 Saudi Arabia lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 89 UAE lentiviral vector market, by product, 2021-2033 (USD Million)
Table 90 UAE lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 91 UAE lentiviral vector market, by end use, 2021-2033 (USD Million)
Table 92 Kuwait lentiviral vector market, by product, 2021-2033 (USD Million)
Table 93 Kuwait lentiviral vector market, by indication, 2021-2033 (USD Million)
Table 94 Kuwait lentiviral vector market, by end use, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Market formulation & validation
Figure 4 Lentiviral Vector market: Market outlook
Figure 5 Lentiviral Vector market: Segment outlook
Figure 6 Lentiviral Vector market: Competitive landscape outlook
Figure 7 Parent market outlook
Figure 8 Lentiviral Vector market driver impact
Figure 9 Lentiviral Vector market restraint impact
Figure 10 Lentiviral Vector market: Product outlook and key takeaways
Figure 11 Lentiviral Vector market: Product movement analysis
Figure 12 1st-generation market estimates and forecasts, 2021-2033 (USD Million)
Figure 13 2nd-generation market estimates and forecasts, 2021-2033 (USD Million)
Figure 14 3rd-generation market estimates and forecasts, 2021-2033 (USD Million)
Figure 15 Lentiviral Vector market: Indication outlook and key takeaways
Figure 16 Lentiviral Vector market: Indication movement analysis
Figure 17 HIV market estimates and forecasts, 2021-2033 (USD Million)
Figure 18 ?-thalassemia market estimates and forecasts, 2021-2033 (USD Million)
Figure 19 X-linked adrenoleukodystrophy market estimates and forecasts, 2021-2033 (USD Million)
Figure 20 Metachromatic leukodystrophy market estimates and forecasts, 2021-2033 (USD Million)
Figure 21 Wiskott-aldrich syndrome market estimates and forecasts, 2021-2033 (USD Million)
Figure 22 Lentiviral Vector market: End Use outlook and key takeaways
Figure 23 Lentiviral Vector market: End Use movement analysis market estimates and forecasts, 2021-2033 (USD Million)
Figure 24 Pharmaceutical and biotechnology companies market estimates and forecasts, 2021-2033 (USD Million)
Figure 25 Academic & research institutes market estimates and forecasts, 2021-2033 (USD Million)
Figure 26 CROs & CMOs market estimates and forecasts, 2021-2033 (USD Million)
Figure 27 Global Lentiviral Vector market: Regional outlook and key takeaways
Figure 28 Global Lentiviral Vector market: Regional movement analysis
Figure 29 North America market estimates and forecasts, 2021-2033 (USD Million)
Figure 30 Key country dynamics
Figure 31 U.S. market estimates and forecasts, 2021-2033 (USD Million)
Figure 32 Key country dynamics
Figure 33 Canada market estimates and forecasts, 2021-2033 (USD Million)
Figure 34 Key country dynamics
Figure 35 Mexico market estimates and forecasts, 2021-2033 (USD Million)
Figure 36 Europe market estimates and forecasts, 2021-2033 (USD Million)
Figure 37 Key country dynamics
Figure 38 UK market estimates and forecasts, 2021-2033 (USD Million)
Figure 39 Key country dynamics
Figure 40 Germany market estimates and forecasts, 2021-2033 (USD Million)
Figure 41 Key country dynamics
Figure 42 France market estimates and forecasts, 2021-2033 (USD Million)
Figure 43 Key country dynamics
Figure 44 Italy market estimates and forecasts, 2021-2033 (USD Million)
Figure 45 Key country dynamics
Figure 46 Spain market estimates and forecasts, 2021-2033 (USD Million)
Figure 47 Key country dynamics
Figure 48 Denmark market estimates and forecasts, 2021-2033 (USD Million)
Figure 49 Key country dynamics
Figure 50 Sweden market estimates and forecasts, 2021-2033 (USD Million)
Figure 51 Key country dynamics
Figure 52 Norway market estimates and forecasts, 2021-2033 (USD Million)
Figure 53 Asia-Pacific market estimates and forecasts, 2021-2033 (USD Million)
Figure 54 Key country dynamics
Figure 55 China market estimates and forecasts, 2021-2033 (USD Million)
Figure 56 Key country dynamics
Figure 57 Japan market estimates and forecasts, 2021-2033 (USD Million)
Figure 58 Key country dynamics
Figure 59 India market estimates and forecasts, 2021-2033 (USD Million)
Figure 60 Key country dynamics
Figure 61 Thailand market estimates and forecasts, 2021-2033 (USD Million)
Figure 62 Key country dynamics
Figure 63 South Korea market estimates and forecasts, 2021-2033 (USD Million)
Figure 64 Key country dynamics
Figure 65 Australia market estimates and forecasts, 2021-2033 (USD Million)
Figure 66 Latin America market estimates and forecasts, 2021-2033 (USD Million)
Figure 67 Key country dynamics
Figure 68 Brazil market estimates and forecasts, 2021-2033 (USD Million)
Figure 69 Key country dynamics
Figure 70 Argentina market estimates and forecasts, 2021-2033 (USD Million)
Figure 71 Middle East and Africa market estimates and forecasts, 2021-2033 (USD Million)
Figure 72 Key country dynamics
Figure 73 South Africa market estimates and forecasts, 2021-2033 (USD Million)
Figure 74 Key country dynamics
Figure 75 Saudi Arabia market estimates and forecasts, 2021-2033 (USD Million)
Figure 76 Key country dynamics
Figure 77 UAE market estimates and forecasts, 2021-2033 (USD Million)
Figure 78 Key country dynamics
Figure 79 Kuwait market estimates and forecasts, 2021-2033 (USD Million)

Companies Mentioned

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • OriGene Technologies Inc.
  • FinVector Oy
  • Sino Biological Inc.
  • Oxford Biomedica
  • Lonza
  • Vector Biolabs
  • Takara Bio Inc.
  • Sirion-Biotech GmbH (Revvity)

Table Information